Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial plasma membrane lipids are essential structural and functional components of the cell envelope in bacteria and fungi, providing a selective permeability barrier and a scaffold for membrane-bound proteins (Epand et al., 2016, PMID: 27532147). In bacteria, these lipids often include phosphatidylglycerol and cardiolipin, which are negatively charged and serve as the primary targets for cationic antimicrobial peptides and drugs like daptomycin, which causes rapid membrane depolarization (Silverman et al., 2003, PMID: 12939442). In fungi, ergosterol is a unique lipid component that maintains membrane integrity and is the target for polyene antifungals such as amphotericin B, which forms lethal pores in the membrane (Baginski & Czub, 2009, PMID: 19149605). Additionally, lipid-linked precursors like Lipid II are critical for cell wall synthesis and are targeted by glycopeptide derivatives to halt peptidoglycan assembly (Schneider & Sahl, 2010, PMID: 20440274). Because these lipids are fundamental to microbial survival and differ significantly from human membrane lipids, they represent a vital target for treating multi-drug resistant infections. The physical disruption of the membrane is a robust mechanism of action that is generally difficult for microbes to overcome through simple genetic mutations.
Direct binding to membrane lipids leading to membrane depolarization, pore formation, and leakage of intracellular contents; or binding to lipid precursors to inhibit cell wall biosynthesis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial plasma membrane lipids.